Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 3,274.15 11.40  | 0.35% 27.25% 74.77 27,575.07
NSE Price: Mar 27 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Mar 27 3,274.15 11.40 0.35% 3,300.00 3,262.75 16,217 3,240.00 - 3,340.00
BSE Mar 27 3,263.65 8.15 0.25% 3,281.00 3,255.50 1,744 3,242.50 - 3,334.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
6M Average Volume: 19,700 P/B: 11.56 NSE Code: GLAXO
52-Week Range: R 2,365.00 - 3,550.00 Dividend Yield: 1.54% BSE Code: 500660
TTM EPS: R 43.54 Book Value: R 281.69 Face Value: R 10
Price Graph
  • Divi's Laboratories (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma* 2.01 5.29 4.65 27.94 14.22 13.28 16.65
S&P BSE Mid Cap -0.12 -4.18 2.41 49.93 18.38 8.90 13.13
S&P BSE Healthcare 15.38 9.09 17.64 69.71 38.13 25.99 20.66
Company's return has been calculated on basis of NSE's price.
As on Mar 27, 2015
*As on Mar 26, 2015
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -3.13 6.63 9.02
Net Profit -14.28 -5.91 0.80
EPS -14.28 -5.91 0.80
Book Value -0.85 0.65 4.78
Average
Operating Margin 27.05 34.28 37.00
Net Margin 17.02 17.50 20.15
Return on Networth 24.10 24.89 27.07
Return on Investment 35.54 36.28 40.11
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -12.84 2.14 2.14
Operating Profit -24.02 -8.19 -8.19
Net Profit -64.79 -61.24 -61.24
EPS -64.79 - -
TTM
Revenue 0.51 4.76 4.76
Operating Profit -2.02 -8.77 -8.77
Net Profit -16.25 -26.52 -26.52
EPS 14.00 118.21 118.21
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 27,575.07 2,667.27 368.80 13.05 24.10 11.56 74.77
Divi's Laboratories 23,949.91 3,007.52 811.21 26.37 28.31 6.58 29.52
Glenmark Pharma. 21,482.46 2,641.04 488.76 18.10 18.99 6.61 42.31
Fund Houses which are invested in the stock
Fund Dec-14 Sep-14 Jun-14 Mar-14 Dec-13
Birla Sun Life Mutual Fund 0.672 0.593 0.128 0.108 0.253
UTI Mutual Fund 0.160 0.152 0.155 0.155 0.762
Tata Mutual Fund 0.065 - - 0.026 0.043
IDBI Mutual Fund 0.011 0.008 0.003 0.003 0.005
Goldman Sachs Mutual Fund 0.005 0.005 0.005 0.009 0.009
ICICI Prudential Mutual Fund 0.002 0.002 0.002 0.001 0.001
Reliance Mutual Fund 0.001 0.001 0.002 - 0.235
IIFL Mutual Fund NA 0.001 0.001 0.003 0.003
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: ajay.a.nadkarni@gsk.com

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad | Phone: 91-040-23420818 | Fax: 91-040-23420814

Email: mailmanager@karvy.com

Website: www.karvycomputershare.com

Related Stocks
Glaxosmithkline Pharma ₹3,274.15 +0.35%
Ajanta Pharma ₹1,204.85 +0.53%
Biocon ₹425.05 -1.48%
Divi's Laboratories ₹1,794.25 -0.65%
Glenmark Pharma. ₹771.75 -2.61%
Pfizer ₹2,152.75 +0.24%
Piramal Enterprises ₹858.95 +0.10%
Sun Pharma Adv. Research ₹470.75 -0.64%
Torrent Pharmaceuticals ₹1,138.25 +0.34%
Wockhardt ₹1,835.05 -1.74%
As on Mar 27